Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors

• Autores principales: Selin Genc (Autor), Bahri Evren (Autor), Onur Selcuk Yigit (Autor), Ibrahim Sahin (Autor), Ramazan Dayanan (Autor), Aleksandra Klisic (Autor), Ayse Erturk (Autor), Filiz Mercantepe (Autor)
• Formato: Libro
• Publicado: MDPI AG, 2024-11-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

<b>Background/Objectives</b>: The antidiabetic effect of SGLT2 inhibitors (SGLT2-is) is based on their ability to increase glucose excretion through urine by inhibiting the kidney-resident SGLT2 protein. Euglycemic diabetic ketoacidosis (EuDKA) is an uncommon but potentially life-threate...